Cargando…
Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus
Dementia is a permanent illness characterized by mental instability, memory loss, and cognitive decline. Many studies have demonstrated an association between diabetes and cognitive dysfunction that proceeds in three steps, namely, diabetes-associated cognitive decrements, mild cognitive impairment...
Autores principales: | Pelle, Maria Chiara, Zaffina, Isabella, Giofrè, Federica, Pujia, Roberta, Arturi, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379573/ https://www.ncbi.nlm.nih.gov/pubmed/37511061 http://dx.doi.org/10.3390/ijms241411301 |
Ejemplares similares
-
Role of a Dual Glucose-Dependent Insulinotropic Peptide (GIP)/Glucagon-like Peptide-1 Receptor Agonist (Twincretin) in Glycemic Control: From Pathophysiology to Treatment
por: Pelle, Maria Chiara, et al.
Publicado: (2021) -
Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
por: Zaffina, Isabella, et al.
Publicado: (2023) -
Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options
por: Pelle, Maria Chiara, et al.
Publicado: (2022) -
Sodium-Glucose Co-transporter-2 Inhibitors and Nephroprotection in Diabetic Patients: More Than a Challenge
por: Provenzano, Michele, et al.
Publicado: (2021) -
COVID-19 and diabetes—Two giants colliding: From pathophysiology to management
por: Pelle, Maria Chiara, et al.
Publicado: (2022)